Prostatis Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-28,272
| Closed | -$132K | – | 190 |
|
|
2023
Q2 | $132K | Buy |
+28,272
| New | +$132K | 0.06% | 126 |
|
|
2023
Q1 | – | Sell |
-5,893
| Closed | -$302K | – | 106 |
|
|
2022
Q4 | $302K | Sell |
5,893
-8
| -0.1% | -$410 | 0.18% | 76 |
|
|
2022
Q3 | $258K | Buy |
5,901
+543
| +10% | +$23.8K | 0.3% | 48 |
|
|
2022
Q2 | $281K | Sell |
5,358
-854
| -14% | -$44.8K | 0.44% | 28 |
|
|
2022
Q1 | $322K | Buy |
6,212
+869
| +16% | +$45K | 0.26% | 53 |
|
|
2021
Q4 | $315K | Buy |
5,343
+78
| +1% | +$4.61K | 0.19% | 71 |
|
|
2021
Q3 | $226K | Buy |
5,265
+5
| +0.1% | +$215 | 0.14% | 90 |
|
|
2021
Q2 | $206K | Sell |
5,260
-300
| -5% | -$11.7K | 0.14% | 100 |
|
|
2021
Q1 | $201K | Buy |
+5,560
| New | +$201K | 0.16% | 94 |
|